nomegestrol

Nomegestrol (), also known as 19-normegestrol, is a steroidal progestin which was patented in 1975 but was never marketed. It is the parent compound of nomegestrol acetate, which is marketed as a progestin.

In the Vinony graph

Vinony's link graph records 367 inbound references to nomegestrol, and connects out to mometasone furoate, abiraterone acetate and aluminium.

Vinony files it under Abandoned drugs, Chemical pages without DrugBank identifier and Drugs with no legal status.

Vinony links it to 7 Wikipedia language editions.

Chemical data

Formula: C21H28O3
Molecular weight: 328.4 g/mol
IUPAC name: (8S,9S,10R,13S,14S,17R)-17-acetyl-17-hydroxy-6,13-dimethyl-1,2,8,9,10,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one

via PubChem

Drug data · ChEMBL

Max clinical phase: Approved
Molecule type: Small molecule

via ChEMBL · EBI

Wikidata facts

Mass: 328.204
Has use: medication

Show 4 more facts

chemical formula: C₂₁H₂₈O₃
isomeric SMILES: CC1=C[C@@H]2[C@H](CC[C@]3([C@H]2CC[C@@]3(C(=O)C)O)C)[C@@H]4C1=CC(=O)CC4
canonical SMILES: CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4C1=CC(=O)CC4
Commons category: Nomegestrol

Sources (3)

via Wikidata · CC0

~1 min read

Encyclopedic overview

2 sections

Contents

See also
References

Nomegestrol shows relatively low affinity for the progesterone receptor, only about 4% of that of progesterone and about 1.6% of that of nomegestrol acetate in one assay.

Excerpted from Wikipedia’s “nomegestrol” article, available under the CC BY-SA 4.0 licence.